Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omacad Softgels
- Development stage
- Unknown
- Lead developer
- Switzer Life Science
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Omacad Softgels is a multi-ingredient nutritional and antioxidant formulation developed and manufactured by Switzer Life Science. It is a branded generic product typically composed of Omega-3 fatty acids (including Eicosapentaenoic Acid and Docosahexaenoic Acid), combined with a variety of botanical extracts such as Ginseng, Ginkgo Biloba, Green Tea Extract, and Grape Seed Extract. The formulation is further enriched with essential vitamins, minerals, and trace elements. Omacad Softgels are marketed as a comprehensive supplement to support cardiovascular health, enhance cognitive function, and provide antioxidant protection against oxidative stress. It is commonly used in the management of nutritional deficiencies and as an adjunct therapy for general metabolic well-being in the Indian pharmaceutical market.
- Brand names
- Omacad Softgels
- Other names
- Omacad
02
Targets
PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on Omacad Softgels.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omacad Softgels.